A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Amlodipine/chlortalidone/losartan (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 17 Nov 2017 According to a Hanmi Pharmaceutical media release, clinical results from this trial were presented at the 47th Korean Society of Hypertension Fall Conference.
- 19 Oct 2017 Results published in the Hanmi Pharmaceutical Media Release.
- 19 Oct 2017 According to a Hanmi Pharmaceutical media release, results were published in SCI-level international scientific journal Clinical Therapeutics.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History